Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.

Cho SR, Benraiss A, Chmielnicki E, Samdani A, Economides A, Goldman SA.

J Clin Invest. 2007 Oct;117(10):2889-902.

2.
3.

Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF.

Benraiss A, Bruel-Jungerman E, Lu G, Economides AN, Davidson B, Goldman SA.

Gene Ther. 2012 May;19(5):483-93. doi: 10.1038/gt.2011.114. Epub 2011 Sep 15. Erratum in: Gene Ther. 2012 May;19(5):582.

5.

Induction of striatal neurogenesis enhances functional recovery in an adult animal model of neonatal hypoxic-ischemic brain injury.

Im SH, Yu JH, Park ES, Lee JE, Kim HO, Park KI, Kim GW, Park CI, Cho SR.

Neuroscience. 2010 Aug 11;169(1):259-68. doi: 10.1016/j.neuroscience.2010.04.038.

PMID:
20610036
6.

Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease.

Benraiss A, Toner MJ, Xu Q, Bruel-Jungerman E, Rogers EH, Wang F, Economides AN, Davidson BL, Kageyama R, Nedergaard M, Goldman SA.

Cell Stem Cell. 2013 Jun 6;12(6):787-99. doi: 10.1016/j.stem.2013.04.014.

7.
8.

Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease.

Pineda JR, Canals JM, Bosch M, Adell A, Mengod G, Artigas F, Ernfors P, Alberch J.

J Neurochem. 2005 Jun;93(5):1057-68.

9.

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.

Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martín-Ibañez R, Muñoz MT, Mengod G, Ernfors P, Alberch J.

J Neurosci. 2004 Sep 1;24(35):7727-39.

10.

Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington's disease delays the onset of the motor phenotype.

Arregui L, Benítez JA, Razgado LF, Vergara P, Segovia J.

Cell Mol Neurobiol. 2011 Nov;31(8):1229-43. doi: 10.1007/s10571-011-9725-y. Epub 2011 Jun 17.

PMID:
21681558
11.

Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease.

Kohl Z, Kandasamy M, Winner B, Aigner R, Gross C, Couillard-Despres S, Bogdahn U, Aigner L, Winkler J.

Brain Res. 2007 Jun 25;1155:24-33. Epub 2007 Apr 21.

PMID:
17512917
12.

Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease.

Giampà C, Montagna E, Dato C, Melone MA, Bernardi G, Fusco FR.

PLoS One. 2013 May 20;8(5):e64037. doi: 10.1371/journal.pone.0064037. Print 2013.

13.

FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.

Jin K, LaFevre-Bernt M, Sun Y, Chen S, Gafni J, Crippen D, Logvinova A, Ross CA, Greenberg DA, Ellerby LM.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18189-94. Epub 2005 Dec 2.

15.

Chemical characterization of newly generated neurons in the striatum of adult primates.

Bédard A, Gravel C, Parent A.

Exp Brain Res. 2006 Apr;170(4):501-12. Epub 2005 Nov 23.

PMID:
16328260
17.

AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment.

Kells AP, Henry RA, Connor B.

Gene Ther. 2008 Jul;15(13):966-77. doi: 10.1038/gt.2008.23. Epub 2008 Mar 6.

PMID:
18323792
18.

Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.

Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ.

J Neurosci. 2004 Mar 3;24(9):2270-6.

19.

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.

Xifró X, Giralt A, Saavedra A, García-Martínez JM, Díaz-Hernández M, Lucas JJ, Alberch J, Pérez-Navarro E.

Neurobiol Dis. 2009 Dec;36(3):461-9. doi: 10.1016/j.nbd.2009.08.012. Epub 2009 Sep 4.

PMID:
19733666
20.

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS.

J Neurophysiol. 2001 Dec;86(6):2667-77.

Items per page

Supplemental Content

Write to the Help Desk